Oligonucleotide Synthesis Market Projected to Reach US$4.189 bn by 2025

As per s new study by Transparency Market Research (TMR), the global oligonucleotide synthesis market is displaying a highly competitive vendor landscape. Thermo Fisher Scientific, DNA Technologies, GE Healthcare, BioAutomation, GeneDesign, Inc., Applied Biosystems, Eurofins Genomics, Sigma-Aldrich Corp., Integrated Kaneka Eurogentec S.A., and Agilent Technologies are some of the key companies operating in the global market. Going forward, this market is likely to witness intensified competition among players in the near future, thanks to the continuous entry of new market participants, states the research report.

The research report on the global market for oligonucleotide synthesis notes that the market stood at US$1.65 bn in 2016. Proliferating at a CAGR of 11.20% during the period from 2017 to 2025, the market’s opportunity is anticipated to reach US$4.18 bn by the end of the forecast period. , reports the market study.

Request A Sample-


North America to Lead Global Oligonucleotide synthesis Market

In this market study, the global oligonucleotide synthesis market is also analyzed on the basis of the regional distribution of this market. North America, Europe, Asia Pacific, and the Rest of the World have been considered as the key geographical segments of this market in this report. North America emerged the dominant regional market in 2016 with nearly one third share in the global market. This regional market is anticipated to maintain its dominance throughout the forecast period, thanks to significant rise in its pharmaceutical industry. The increasing prevalence of genetic diseases in the region and the consequent demand for newer and advanced drugs is also projected to support the North America market for oligonucleotide synthesis in the years to come.

Leave a Reply

Your email address will not be published. Required fields are marked *